Seattle Startup Vedana Therapeutics Raises $46 Million to Develop Dual-Target Migraine Antibodies
On Wednesday, Vedana Therapeutics, a Seattle‑based biotech that has been operating in stealth, announced it has closed...
Read story →
On Wednesday, Vedana Therapeutics, a Seattle‑based biotech that has been operating in stealth, announced it has closed...
Read story →